GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 156 filers reported holding GERON CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392 | -33.2% | 184,931 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $587 | +40.1% | 183,007 | -5.2% | 0.00% | 0.0% |
| Q1 2023 | $419 | -32.1% | 192,946 | -24.4% | 0.00% | 0.0% |
| Q4 2022 | $617 | -99.9% | 255,081 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $597,000 | +114.0% | 255,127 | +41.6% | 0.00% | – |
| Q2 2022 | $279,000 | +13.4% | 180,119 | -0.4% | 0.00% | – |
| Q1 2022 | $246,000 | +11.8% | 180,872 | +0.2% | 0.00% | – |
| Q4 2021 | $220,000 | +9.5% | 180,470 | +23.0% | 0.00% | – |
| Q3 2021 | $201,000 | -34.5% | 146,736 | -32.7% | 0.00% | – |
| Q2 2021 | $307,000 | -10.0% | 217,988 | +1.1% | 0.00% | – |
| Q1 2021 | $341,000 | +6.6% | 215,600 | +7.2% | 0.00% | – |
| Q4 2020 | $320,000 | +10.0% | 201,100 | +20.4% | 0.00% | – |
| Q3 2020 | $291,000 | -1.7% | 167,000 | +22.8% | 0.00% | – |
| Q2 2020 | $296,000 | +136.8% | 136,000 | +29.9% | 0.00% | – |
| Q1 2020 | $125,000 | -12.0% | 104,700 | 0.0% | 0.00% | – |
| Q4 2019 | $142,000 | -38.0% | 104,700 | -39.2% | 0.00% | – |
| Q3 2019 | $229,000 | -5.8% | 172,300 | 0.0% | 0.00% | – |
| Q2 2019 | $243,000 | +29.9% | 172,300 | +52.6% | 0.00% | – |
| Q1 2019 | $187,000 | +65.5% | 112,900 | 0.0% | 0.00% | – |
| Q4 2018 | $113,000 | -64.0% | 112,900 | -36.7% | 0.00% | – |
| Q3 2018 | $314,000 | -38.3% | 178,300 | +20.1% | 0.00% | -100.0% |
| Q2 2018 | $509,000 | -17.1% | 148,500 | +2.8% | 0.00% | 0.0% |
| Q1 2018 | $614,000 | +136.2% | 144,400 | 0.0% | 0.00% | – |
| Q4 2017 | $260,000 | -17.5% | 144,400 | 0.0% | 0.00% | – |
| Q3 2017 | $315,000 | -21.2% | 144,400 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $400,000 | +22.0% | 144,400 | -0.0% | 0.00% | – |
| Q1 2017 | $328,000 | +9.7% | 144,401 | +0.0% | 0.00% | – |
| Q4 2016 | $299,000 | -8.3% | 144,400 | 0.0% | 0.00% | – |
| Q3 2016 | $326,000 | -15.8% | 144,400 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $387,000 | -8.3% | 144,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $422,000 | -39.6% | 144,400 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $699,000 | +75.2% | 144,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $399,000 | -43.1% | 144,400 | -11.9% | 0.00% | 0.0% |
| Q2 2015 | $701,000 | – | 163,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 5,732,770 | $7,854,000 | 1.22% |
| RA Capital Management | 30,126,299 | $41,273,000 | 0.57% |
| NEA Management Company, LLC | 13,461,538 | $18,442,000 | 0.22% |
| Virtus ETF Advisers LLC | 146,618 | $201,000 | 0.09% |
| Forefront Analytics, LLC | 82,336 | $113,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 226,098 | $310,000 | 0.03% |
| Summit X, LLC | 84,077 | $114,000 | 0.03% |
| Poehling Capital Management, INC. | 53,000 | $73,000 | 0.02% |
| Arnhold LLC | 154,700 | $212,000 | 0.02% |
| Piscataqua Savings Bank | 12,500 | $17,000 | 0.02% |